Searchable abstracts of presentations at key conferences in endocrinology

ea0041gp97 | Diabetes (2) | ECE2016

Real-world comparative effectiveness of liraglutide, exenatide once weekly and lisixenatide in patients with type 2 diabetes mellitus

Marco Martinez Amparo , Martinez Garcia Ana , Herranz Antolin Sandra , Lopez Gallardo Gemma , Jose Pines Corrales Pedro , Quilez Toboso Rosa , Aguirre Sanchez-Covisa Miguel , Joaquin Alfaro Jose

The improvement of glycemic control and body weight reduction by GLP-1 receptor agonist (GLP1RA) has been demostred in randomized clinical trials, but comparative studies of the efficacy of different GLP1RA in real world and clinical practice setting are limited.Objectives: To compare the efficacy of liraglutide (LIRA), exenatide once weekly (EQW), and lisixenatide (LIXI) treatment in a real-world and clinical practice setting.Meth...